UB Paderborn / Katalog / Suche / in CDI

Cannabidiol for the treatment of psychosis in Parkinson’s disease

Journal of psychopharmacology (Oxford), 2009-11, Vol.23 (8), p.979-983

2009

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol can improve complex sleep‐related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series

Journal of clinical pharmacy and therapeutics, 2014-10, Vol.39 (5), p.564-566

2014

Link zum Volltext

Verfügbarkeit prüfen

Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder

European psychiatry, 2023-03, Vol.66 (S1), p.S225-S226

2023

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report

Journal of clinical pharmacy and therapeutics, 2013-04, Vol.38 (2), p.162-164

2013

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal follow-up of cavum septum pellucidum and adhesio interthalamica alterations in first-episode psychosis: a population-based MRI study

Psychological medicine, 2012-12, Vol.42 (12), p.2523-2534

2012

Link zum Volltext

Verfügbarkeit prüfen

Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model

Brazilian journal of medical and biological research, 2018-01, Vol.51 (5), p.e7132-e7132

2018

Link zum Volltext

Verfügbarkeit prüfen

Cortical thinning of the right anterior cingulate cortex in spider phobia: A magnetic resonance imaging and spectroscopy study

Brain research, 2014-08, Vol.1576, p.35-42

2014

Link zum Volltext

Verfügbarkeit prüfen

Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review

Brazilian journal of medical and biological research, 2012-03, Vol.45 (3), p.179-186

2012

Link zum Volltext

Verfügbarkeit prüfen

Whole-Brain Voxel-Based Morphometry in Kallmann Syndrome Associated with Mirror Movements

American journal of neuroradiology : AJNR, 2008-10, Vol.29 (9), p.1799-1804

2008

Link zum Volltext

Verfügbarkeit prüfen

Phytocannabinoids and epilepsy

Journal of clinical pharmacy and therapeutics, 2015-04, Vol.40 (2), p.135-143

2015

Link zum Volltext

Verfügbarkeit prüfen

Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?

Psychological medicine, 2017-04, Vol.47 (5), p.981-982

2017

Link zum Volltext

Verfügbarkeit prüfen

Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia

Schizophrenia research, 2016-04, Vol.172 (1), p.220-221

2016

Link zum Volltext

Verfügbarkeit prüfen

Postural balance in patients with social anxiety disorder

Brazilian journal of medical and biological research, 2012-01, Vol.45 (1), p.38-42

2012

Link zum Volltext

Verfügbarkeit prüfen

Ageing and surface EMG activity patterns of masticatory muscles

Journal of oral rehabilitation, 2010-04, Vol.37 (4), p.248-255

2010

Link zum Volltext

Verfügbarkeit prüfen

Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update

Brazilian journal of medical and biological research, 2009-11, Vol.42 (11), p.1002-1014

2009

Link zum Volltext

Verfügbarkeit prüfen

Electromyographic analysis of masseter and temporal muscles, bite force, masticatory efficiency in medicated individuals with schizophrenia and mood disorders compared with healthy controls

Journal of oral rehabilitation, 2014-06, Vol.41 (6), p.399-408

2014

Link zum Volltext

Verfügbarkeit prüfen

A False Case of Clozapine-Resistant Schizophrenia

Case Reports in Medicine, 2010-01, Vol.2010, p.534027-3

2010

Link zum Volltext

Verfügbarkeit prüfen

Mood Disorder Due to a General Medical Condition with Manic Features

Case reports in medicine, 2009-01, Vol.2009, p.871365-4

2009

Link zum Volltext

Verfügbarkeit prüfen

Intoxicación por ayahuasca

Medicina clínica, 2017, Vol.149 (10), p.461-462

2017

Link zum Volltext

Verfügbarkeit prüfen

A structured interview guide increases Brief Psychiatric Rating Scale reliability in raters with low clinical experience

Acta psychiatrica Scandinavica, 2001-06, Vol.103 (6), p.465-470

2001

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Brazilian journal of medical and biological research, 2006-04, Vol.39 (4), p.421-429

2006

Link zum Volltext

Verfügbarkeit prüfen

Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia

Brazilian journal of medical and biological research, 2008-12, Vol.41 (12), p.1132-1141

2008

Link zum Volltext

Verfügbarkeit prüfen

NMDA and AMPA/Kainate Glutamatergic Receptors in the Prelimbic Medial Prefrontal Cortex Modulate the Elaborated Defensive Behavior and Innate Fear-Induced Antinociception Elicited by GABAA Receptor Blockade in the Medial Hypothalamus

Cerebral cortex (New York, N.Y. 1991), 2014-06, Vol.24 (6), p.1518-1528

2014

Link zum Volltext

Verfügbarkeit prüfen

Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease

Age and ageing, 2013-09, Vol.42 (5), p.645-649

2013

Link zum Volltext

Verfügbarkeit prüfen

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges

Risk management and healthcare policy, 2021-01, Vol.14, p.901-910

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Cannabidiol for the treatment of psychosis in Parkinson’s disease

Cannabidiol can improve complex sleep‐related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series

Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report

Longitudinal follow-up of cavum septum pellucidum and adhesio interthalamica alterations in first-episode psychosis: a population-based MRI study

Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model

Cortical thinning of the right anterior cingulate cortex in spider phobia: A magnetic resonance imaging and spectroscopy study

Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review

Whole-Brain Voxel-Based Morphometry in Kallmann Syndrome Associated with Mirror Movements

Phytocannabinoids and epilepsy

Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?

Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia

Postural balance in patients with social anxiety disorder

Ageing and surface EMG activity patterns of masticatory muscles

Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update

Electromyographic analysis of masseter and temporal muscles, bite force, masticatory efficiency in medicated individuals with schizophrenia and mood disorders compared with healthy controls

A False Case of Clozapine-Resistant Schizophrenia

Mood Disorder Due to a General Medical Condition with Manic Features

Intoxicación por ayahuasca

A structured interview guide increases Brief Psychiatric Rating Scale reliability in raters with low clinical experience

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia

NMDA and AMPA/Kainate Glutamatergic Receptors in the Prelimbic Medial Prefrontal Cortex Modulate the Elaborated Defensive Behavior and Innate Fear-Induced Antinociception Elicited by GABAA Receptor Blockade in the Medial Hypothalamus

Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges

Suchergebnisse filtern